A new study presented at UEG Week 2025 reveals that both sugar-sweetened and artificially sweetened beverages are linked to an increased risk of metabolic dysfunction-associated steatotic liver disease (MASLD). The research found that low or no-sugar drinks were even associated with a higher risk of liver-related mortality, challenging the perception of them being a healthier alternative.
A new study presented at UEG Week 2025 reveals that both sugar-sweetened and artificially sweetened beverages are linked to an increased risk of metabolic dysfunction-associated steatotic liver disease (MASLD). The research found that low or no-sugar drinks were even associated with a higher risk of liver-related mortality, challenging the perception of them being a healthier alternative.